SNMMI provides update on COVID-19 vaccine and PET/CT
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has updated it...Read more on AuntMinnie.comRelated Reading: SNMMI issues new guidelines on V/Q scans FDG-PET/CT shows COVID-19 vaccine uptake PET/CT guidance offers valuable approach to lung biopsies SNMMI 2020: PSMA-PET/CT changes prostate cancer management SNMMI 2020: How nuclear medicine handled COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 31, 2021 Category: Radiology Source Type: news

Lantheus buys rights to PET oncology imaging agent
Lantheus Medical Imaging parent company Lantheus Holdings said it has purchase...Read more on AuntMinnie.comRelated Reading: Lantheus experiences net loss in Q4, full fiscal year Lantheus touts ASCO GU talks with PSMA agent Lantheus submits drug master file for imaging biomarker Point Biopharma to use Lantheus' PyL in clinical trial Lantheus divests Puerto Rico nuclear medicine businesses (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 30, 2021 Category: Radiology Source Type: news

Dutch look for answers to fix nuclear medicine training
Is there a way to stem the declining numbers of residents pursuing specialtie...Read more on AuntMinnie.comRelated Reading: Survey finds many radiologists still fear being replaced by AI SNMMI 2020: Medical students key to the specialty's future ABNM, ABR scrap plan to revamp nuclear medicine training Proposal would dissolve ABNM, fold functions into ABR Nuclear medicine residents see 'dismal' job market (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 26, 2021 Category: Radiology Source Type: news

New treatment proves more effective and less toxic for neuroendocrine tumor patients
(Society of Nuclear Medicine and Molecular Imaging) A new treatment for late-stage neuroendocrine tumors (NETs) has been found to be more effective and have fewer side effects than the current standard of care, according to research published in the March issue of The Journal of Nuclear Medicine. The novel peptide receptor radionuclide therapy holds promise to reduce mortality among NET patients and decrease the financial burden of their continual treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 22, 2021 Category: Cancer & Oncology Source Type: news

Immuno-PET can give physicians early insight into tumor response to targeted therapy
(Society of Nuclear Medicine and Molecular Imaging) Immuno-positron emission tomography (PET) imaging can provide early insight into a tumor's response to targeted therapy, allowing physicians to select the most effective treatment for patients who have cancer. The new research was published in the March issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 12, 2021 Category: International Medicine & Public Health Source Type: news

BWXT, GMS form joint venture for Asia-Pacific
BWX Technologies (BWXT) subsidiary and medical isotope and radiopharmaceutica...Read more on AuntMinnie.comRelated Reading: BWXT appoints new president for BWXT ITG Canada FDA approves BWXT's radiopharmaceutical BWXT completes acquisition of Nordion business BWXT selects Mo-99 irradiation provider GMS to divest Chinese nuclear medicine business (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 9, 2021 Category: Radiology Source Type: news

NorthStar, IBA expand Tc-99m collaboration
NorthStar Medical Radioisotopes and proton therapy developer Ion Beam Application...Read more on AuntMinnie.comRelated Reading: NorthStar reorganizes to advance nuclear medicine agents IBA adds CBCT to 2 proton therapy centers NorthStar promotes Estrum to executive vice president IBA receives 1st payment from Chinese licensing deal IBA secures large proton therapy contract in China NorthStar, Monopar team up to create COVID-19 therapies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 8, 2021 Category: Radiology Source Type: news

Nuclear medicine
(Source: ScienceNOW)
Source: ScienceNOW - March 4, 2021 Category: Science Authors: Normile, D. Tags: Asia/Pacific News, Medicine, Diseases, Scientific Community Feature Source Type: news

Who Gets Pott ’ s Puffy Tumor?
Discussion Pott’s puffy tumor (PPT) was first described by Sir Percivall Pott in 1775 and who also described other orthopaedic and oncological diseases subsequently named for him. “It is a subperiosteal abscess of the anterior wall of the frontal sinus associated with underlying frontal osteomyelitis.” The tender edema and swelling of the forehead is the sign of PPT. Associated fever, headache, and rhinorrhea along with similar problems such as postnasal drip or nasal congestion are common. Associated ophthalmological problems include peri-orbital or eyelid edema and/or preseptal cellulitis. Ptosis and di...
Source: PediatricEducation.org - March 1, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Lantheus experiences net loss in Q4, full fiscal year
A slight increase in revenue for the fourth quarter wasn't enough to offse...Read more on AuntMinnie.comRelated Reading: Lantheus touts ASCO GU talks with PSMA agent Lantheus submits drug master file for imaging biomarker Point Biopharma to use Lantheus' PyL in clinical trial Lantheus divests Puerto Rico nuclear medicine businesses FDA clears Lantheus' AI bone software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 27, 2021 Category: Radiology Source Type: news

SNMMI confirms Medicare reimbursement error for Cerianna
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) said that th...Read more on AuntMinnie.comRelated Reading: SNMMI, Zionexa call out CMS for reimbursement error SNMMI to hold 2021 annual meeting virtually SNMMI urges fast-track review of Technegas for V/Q scans SNMMI: Imagers should get COVID-19 shots early Imaging agent for breast cancer PET gets FDA nod (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 24, 2021 Category: Radiology Source Type: news

Molecular imaging determines effectiveness of novel metastatic breast cancer treatment
(Society of Nuclear Medicine and Molecular Imaging) Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy. According to research published in the February issue of The Journal of Nuclear Medicine, positron emission tomography (PET) imaging using an imaging agent called 18F-fluoroestradiol can help to determine which patients could benefit from treatments that could spare them from unnecessary chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2021 Category: Cancer & Oncology Source Type: news

RadQual signs distribution deal with LEA
Radioisotope manufacturer International Isotope's RadQual nuclear medicine quality-contro...Read more on AuntMinnie.comRelated Reading: International Isotopes' Q1 revenue declines International Isotopes revenues slide in 2019 International Isotopes receives FDA nod for I-131 Revenue slips at International Isotopes in Q3 International Isotopes posts Q1 decreases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 9, 2021 Category: Radiology Source Type: news

SNMMI, Zionexa call out CMS for reimbursement error
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is teaming u...Read more on AuntMinnie.comRelated Reading: SNMMI urges fast-track review of Technegas for V/Q scans SNMMI: Imagers should get COVID-19 shots early SNMMI celebrates 60th anniversary with special issue New x-ray systems mark Siemens exhibit at RSNA 2020 Imaging agent for breast cancer PET gets FDA nod (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2021 Category: Radiology Source Type: news

Joint radionuclide therapy-immunotherapy approach effective in prostate cancer model
(Society of Nuclear Medicine and Molecular Imaging) A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal of Nuclear Medicine. The results of the murine study indicate that radionuclide therapy promotes prostate cancer immunogenicity, provoking a cellular response that makes the tumors more receptive to immunotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 8, 2021 Category: Cancer & Oncology Source Type: news

Lantheus touts ASCO GU talks with PSMA agent
Lantheus Holdings, parent company of Lantheus Medical Imaging, along with it...Read more on AuntMinnie.comRelated Reading: Lantheus submits drug master file for imaging biomarker Point Biopharma to use Lantheus' PyL in clinical trial Lantheus divests Puerto Rico nuclear medicine businesses FDA clears Lantheus' AI bone software Sofie, Lantheus ink deal for prostate cancer imaging agent (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2021 Category: Radiology Source Type: news

SNMMI to hold 2021 annual meeting virtually
For the second year in a row, the Society of Nuclear Medicine and Molecula...Read more on AuntMinnie.comRelated Reading: SNMMI urges fast-track review of Technegas for V/Q scans SNMMI: Imagers should get COVID-19 shots early SNMMI celebrates 60th anniversary with special issue Nuclear medicine groups oppose Humana PET/CT policy SNNMI joins doc groups criticizing 'COVID-19 inflation' theory (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 2, 2021 Category: Radiology Source Type: news

BARC evolves design for 1st PPP research reactor for nuclear medicine
The state-run the Department of Atomic Energy (DAE) will share the technology of production of a variety of nuclear medicines and the private entities will get exclusive rights to process and market the isotopes produced in the research reactor, in lieu of investing in the reactor and processing facilities, an official statement said. (Source: The Economic Times)
Source: The Economic Times - January 29, 2021 Category: Consumer Health News Source Type: news

Detectnet PET radiotracer gets permanent HCPCS code
Biotechnology firm RadioMedix and nuclear medicine company Curium said that...Read more on AuntMinnie.comRelated Reading: Study suggests extending Cu-64 tracer window to 3 hours CMS grants pass-through status for Detectnet ITM receives drug master file for gallium generator RadioMedix, Curium win FDA clearance for Detectnet Curium files for approvals of germanium-68 tracer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 26, 2021 Category: Radiology Source Type: news

Radiography, nuclear medicine enrollment down in 2020
The number of students enrolled in radiography and nuclear medicine education...Read more on AuntMinnie.comRelated Reading: ASRT touts role of technologists during COVID-19 ASRT expands scholarships for 2021-2022 ASRT, Hologic partner on radiographer scholarships ASRT, Elekta to provide $10K for Black students ASRT, Canon announce Safety First winners (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 25, 2021 Category: Radiology Source Type: news

SNMMI urges fast-track review of Technegas for V/Q scans
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has sent a letter...Read more on AuntMinnie.comRelated Reading: SNMMI: Imagers should get COVID-19 shots early SNMMI celebrates 60th anniversary with special issue Nuclear medicine groups oppose Humana PET/CT policy SNMMI updates ventilation study guidance Jubilant DraxImage, Cyclopharm ink deal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 21, 2021 Category: Radiology Source Type: news

What Are Potential Problems of Congenital Lung Malformations?
Discussion Congenital lung malformations (CLM) are commonly identified with prenatal ultrasound and occur in ~1:2400 live births. The natural history shows that lesions may remain the same, enlarge or appear to disappear. There is a wide-range of clinical manifestations. Patients may be asymptomatic or symptomatic at birth and often develop symptoms later. The overall natural history is difficult to ascertain as there are fewer studies done in older children and adults. Those that are done often lack a good denominator by which to judge the incidence or prevalence. Resection is carried out usually if a patient is symptomat...
Source: PediatricEducation.org - January 18, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

IAEA launches project on software dosimetry
The International Atomic Energy Agency (IAEA) has launched a project to investigate...Read more on AuntMinnie.comRelated Reading: IAEA expands SAFRON to support radionuclide therapy Nuclear medicine guidelines promote COVID-19 safety IAEA publishes SPECT/CT usage guide IAEA launches competition for radiation safety IAEA offers CT radiation protection course in Spanish (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 15, 2021 Category: Radiology Source Type: news

Lantheus submits drug master file for imaging biomarker
Lantheus Holdings, parent company of Lantheus Medical Imaging, said that it...Read more on AuntMinnie.comRelated Reading: Point Biopharma to use Lantheus' PyL in clinical trial Lantheus divests Puerto Rico nuclear medicine businesses FDA clears Lantheus' AI bone software Sofie, Lantheus ink deal for prostate cancer imaging agent Lantheus reports mixed Q3 results (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 12, 2021 Category: Radiology Source Type: news

Potential jurors favor use of artificial intelligence in precision medicine
(Society of Nuclear Medicine and Molecular Imaging) Physicians who follow artificial intelligence (AI) advice may be considered less liable for medical malpractice than is commonly thought, according to a new study of potential jury candidates in the U.S. Published in the January issue of The Journal of Nuclear Medicine (JNM). The study provides the first data related to physicians' potential liability for using AI in personalized medicine, which can often deviate from standard care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 11, 2021 Category: International Medicine & Public Health Source Type: news

Report: COVID-19 causing radioisotope delays
A drop in the volume of passenger airline travel is causing delays in the shipment...Read more on AuntMinnie.comRelated Reading: Travel cards could help radiopharma patients avoid delays Nuclear medicine guidelines promote COVID-19 safety KLM commits to deliver radioisotopes to U.S. Firms partner to meet global medical isotope needs (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 4, 2021 Category: Radiology Source Type: news

SNMMI: Imagers should get COVID-19 shots early
Imaging professionals should be considered among the healthcare personnel prioritized...Read more on AuntMinnie.comRelated Reading: SNMMI celebrates 60th anniversary with special issue Nuclear medicine groups oppose Humana PET/CT policy SNNMI joins doc groups criticizing 'COVID-19 inflation' theory SNMMI releases feedback on proposed 2021 MPFS Groups tout value of nuclear medicine to Congress (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 17, 2020 Category: Radiology Source Type: news

New theranostic approach reduces tumor volume and increases survival in NET study
(Society of Nuclear Medicine and Molecular Imaging) A pair of copper radionuclides that target the somatostatin receptor overexpressed in neuroendocrine tumors has proven successful in identifying tumors and improving survival. According to new research published in the December issue ofThe Journal of Nuclear Medicine, the imaging agent 64Cu-CuSarTate produced high-quality positron emission tomography (PET) images in a mouse model of neuroendocrine tumors, while its therapeutic counterpart, 67Cu-CuSarTate, was highly effective in reducing tumor volume and extending lifespan. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 16, 2020 Category: Cancer & Oncology Source Type: news

SNMMI celebrates 60th anniversary with special issue
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is celebrating...Read more on AuntMinnie.comRelated Reading: Nuclear medicine groups oppose Humana PET/CT policy SNNMI joins doc groups criticizing 'COVID-19 inflation' theory Imaging societies seek RVU budget neutrality waiver SNMMI releases feedback on proposed 2021 MPFS Groups tout value of nuclear medicine to Congress (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2020 Category: Radiology Source Type: news

PET imaging tracer proves effective for diagnosing and managing rare CNS B-cell lymphoma
(Society of Nuclear Medicine and Molecular Imaging) Positron emission tomography (PET) imaging with 68Ga-pentixafor is an effective diagnostic tool for central nervous system (CNS) B-cell lymphoma, according to a proof-of-concept study published in the December issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2020 Category: Cancer & Oncology Source Type: news

The Journal of Nuclear Medicine celebrates 60 years of research
(Society of Nuclear Medicine and Molecular Imaging) The Journal of Nuclear Medicine (JNM) has issued a special supplement commemorating six decades of leadership in the field of nuclear medicine, molecular imaging and therapy.The supplement features a collection of the most influential and frequently cited manuscripts in JNM's history, representing seminal discoveries and scientific contributions that shaped the future of medicine. Invited perspectives from world leaders in nuclear medicine, molecular imaging, and theranostics explain why each of these articles had such an enormous impact. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 10, 2020 Category: Cancer & Oncology Source Type: news

Point Biopharma to use Lantheus' PyL in clinical trial
Point Biopharma will use Lantheus Medical Imaging's PyL radiopharmaceutical...Read more on AuntMinnie.comRelated Reading: Lantheus divests Puerto Rico nuclear medicine businesses Lantheus revenue plummets 23% in Q2 Lantheus to discuss PyL imaging agent at SNMMI 2020 ITM signs supply deals with Point Biopharma Lantheus completes Progenics purchase (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 9, 2020 Category: Radiology Source Type: news

Lantheus divests Puerto Rico nuclear medicine businesses
Lantheus Holdings is selling its radiopharmacy and its PET manufacturing facility...Read more on AuntMinnie.comRelated Reading: FDA clears Lantheus' AI bone software Sofie, Lantheus ink deal for prostate cancer imaging agent Lantheus completes Progenics purchase Lantheus inks radiopharma deal with NanoMab (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 3, 2020 Category: Radiology Source Type: news

Mayo Clinic in Florida's Division of Nuclear Medicine evolving to meet growing needs
JACKSONVILLE, Fla. -- Since 2018, the Division of Nuclear Medicine at Mayo Clinic in Florida has undergone a dramatic evolution, adding to its footprint, equipment and staff. Through this transformation, the division has added to its research and clinical capabilities, and now offers nuclear medicine therapies. Nuclear Medicine is part of the Department of Radiology. [...] (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - December 2, 2020 Category: Hospital Management Source Type: news

UCLA, UCSF gain FDA approval for prostate cancer imaging technique
The University of California ’s two nationally ranked medical centers, UCSF and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the t umors have migrated.Known as prostate-specific membrane  antigen PET imaging, or PSMA PET, the technique uses positron emission tomography in conjunction with a PET-sensitive drug that is highly effective in detecting prostate cancer throughout the body so that it can be better and mor...
Source: UCLA Newsroom: Health Sciences - December 1, 2020 Category: Universities & Medical Training Source Type: news

UCLA, UCSF gain FDA approval for prostate cancer imaging technique
(University of California - Los Angeles Health Sciences) The University of California's two nationally ranked medical centers, UCSF and UCLA, and their nuclear medicine teams have obtained approval from the US Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 1, 2020 Category: Cancer & Oncology Source Type: news

Multi-center, multi-tracer PET studies harmonized to detect neuroinflammation in ALS
(Society of Nuclear Medicine and Molecular Imaging) A novel ALS (amyotrophic lateral sclerosis) study has pooled data from multiple sites to effectively visualize neuroinflammation, which is key to developing drugs to treat the disease. Pooling data acquired from different scanners, different neuroinflammation positron emission tomography (PET) markers and different sites enhanced researchers' ability to detect neuroinflammation in ALS patients. This research was published in the November issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 1, 2020 Category: International Medicine & Public Health Source Type: news

How Common Are Bone Spurs in Young Athletes?
Discussion The terminology of abnormal calcification of soft tissues and uses of the terms is often muddied. Especially as the causes may be similar and multiple adjacent tissues may be involved. An exostosis is an abnormal proliferation of bone from the joint. They can appear in various forms and in many locations. An osteophyte is also known as a bone spur and is type of exostosis. Osteophytes are thought to be periosteal or synovial mesenchymal stems cells that become calcified. They usually have a more narrow or pointed projection from the joint. Osteophytes are a very common feature of osteoarthritis. Enthesophytes a...
Source: PediatricEducation.org - November 30, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

STAT honors 'Wunderkind' for pioneering work at UVA on focused ultrasound, cancer
(University of Virginia Health System) Health news site STAT has honored Natasha Sheybani, Ph.D., as one of the next generation of scientific superstars for her work in focused ultrasound, cancer immunology and nuclear medicine while a graduate student at the University of Virginia. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 16, 2020 Category: Cancer & Oncology Source Type: news

Nuclear medicine groups oppose Humana PET/CT policy
Groups that represent nuclear medicine physicians have voiced their opposition...Read more on AuntMinnie.comRelated Reading: SNNMI joins doc groups criticizing 'COVID-19 inflation' theory Imaging societies seek RVU budget neutrality waiver SNMMI releases feedback on proposed 2021 MPFS Groups tout value of nuclear medicine to Congress SNMMI selects Wagner-Torizuka fellowship winners (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 12, 2020 Category: Radiology Source Type: news

Digirad to sell mobile imaging division
Nuclear medicine equipment and services firm Digirad has entered into an agreement...Read more on AuntMinnie.comRelated Reading: Digirad posts drop in Q2 Corindus stockholders approve acquisition by Siemens Digirad reports continued revenue decline in Q4, 2018 Digirad stock faces Nasdaq sanction Digirad CFO to leave company (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 5, 2020 Category: Radiology Source Type: news

What Are Common Presentations for Factitious Disorder?
Discussion Factitious disorder (FD) is when patients fabricate illness in themselves or another person without obvious gain. FD has had other terminology and in the past has been called Munchausen Syndrome (if FD in themselves) or Munchausen Syndrome by proxy or FD by proxy (if FD being perpetuated in another person). The current DSM-V terminology is FD imposed on self or FD imposed on another. Malingering (sometimes referred to as simulation) is similar but those that fabricate illness or medical need have an obvious external reward such as gaining access to public social service benefits, free hospital room and board, or...
Source: PediatricEducation.org - November 2, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

SNNMI joins doc groups criticizing 'COVID-19 inflation' theory
A wide range of physician groups -- including the Society of Nuclear Medicine...Read more on AuntMinnie.comRelated Reading: Neuroradiologists pen letter opposing Atlas HHS renews public health emergency declaration Conservative pundit offers support for Atlas Health groups urge caution on COVID-19 vaccine Stanford Atlas critics hit with lawyer's letter (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 27, 2020 Category: Radiology Source Type: news

What Causes Joint Pain?
DiscussionMusculoskeletal problems are common problems in pediatric practice with up to 15% of acute care visits being for this problem. Joint pain is a common concern for families but the differential diagnosis is extensive and needs thoughtful consideration. History is a key to discerning the potential diagnosis but also in guiding the physical examination and laboratory examination. Family history especially for systemic diseases should be considered. On physical examination all joints should be examined include sacroiliac and temporomandibular joints. Is this arthritis or arthralgia? Distinction between inflammatory...
Source: PediatricEducation.org - October 26, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Disinfect the air, say ultrasound experts from China
Chinese ultrasound experts advised disinfecting both surfaces and the room...Read more on AuntMinnie.comRelated Reading: Contamination a worry for US-guided IV procedures Lung ultrasound helps physicians manage COVID-19 SDMS releases ultrasound infection control guidelines SARS helped Singapore department prepare for COVID-19 Wuhan nuclear medicine docs give COVID-19 safety advice (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 21, 2020 Category: Radiology Source Type: news

RayzeBio raises $45M to advance radiopharmaceuticals
RayzeBio has raised $45 million in a round of series A financing to advance...Read more on AuntMinnie.comRelated Reading: Groups tout value of nuclear medicine to Congress Nuclear medicine volume plummets due to COVID-19 NorthStar heads toward new radioisotope production (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 14, 2020 Category: Radiology Source Type: news

AI aids detection of metastasis on bone scintigraphy
An artificial intelligence (AI) model was able to help nuclear medicine physicians...Read more on AuntMinnie.comRelated Reading: AI algorithm detects COVID, flu, other pneumonia Screening saves lives of women with high-risk tumors AMVC Fall 2020: AI can reshape radiology post-COVID-19 CT radiomics predicts esophageal cancer outcomes What will be the killer apps for AI in MRI? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 14, 2020 Category: Radiology Source Type: news

Imaging societies seek RVU budget neutrality waiver
The Society of Nuclear Medicine and Molecular Imaging has joined with several...Read more on AuntMinnie.comRelated Reading: SNMMI releases feedback on proposed 2021 MPFS Groups tout value of nuclear medicine to Congress Radiology's declining reimbursement spans over a decade Medicare proposes major cut to radiology for 2021 Radiology payments to be lower under 2021 MPFS, HOPPS (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 13, 2020 Category: Radiology Source Type: news

Novel Radioimmunotherapy Reverses Resistance to Commonly Used Lymphoma Drug
(Society of Nuclear Medicine and Molecular Imaging) A new radioimmunotherapy has proven effective in reversing resistance to the most commonly used lymphoma drug, rituximab, according to research published in the October issue of The Journal of Nuclear Medicine. When used in combination with rituximab, 177Lu-lilotomab-satetraxetan was shown to substantially increase rituximab binding and rituximab-mediated antibody-dependent cellular cytotoxicity (ADCC) activity, resulting in significant tumor growth delay in a non-Hodgkin's lymphoma mouse model. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 8, 2020 Category: Cancer & Oncology Source Type: news

Cerenkov luminescence imaging identifies surgical margin status in radical prostatectomy
(Society of Nuclear Medicine and Molecular Imaging) A new intraoperative imaging technique, Cerenkov luminescence imaging (CLI), can accurately assess surgical margins during radical prostatectomy, according to a first-in-human research published in the October issue of The Journal of Nuclear Medicine. The feasibility study showed that 68Ga-PSMA CLI can image the entire excised prostate specimen's surface to detect prostate cancer tissue at the resection margin. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 7, 2020 Category: Cancer & Oncology Source Type: news